The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 24.04%.However, over the last six months, we can see a weaker performance of 53.07%. Over the last 30 days, the price of TEVA has leaped by -3.93%. And in the last five days, it has fallen by -2.63%.
Teva- Pharmaceutical Industries Ltd. ADR experienced a rather steady stock market performance. The highest value in the past year was recorded at $14.47 on 04/08/24 and the lowest value was $7.09 on 05/31/23.
52-week price history of TEVA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is -10.47% away from its 52-week high, while its distance from the 52-week low is 82.78%. The stock’s price range during this period has varied between$7.09 and $14.47. The Teva- Pharmaceutical Industries Ltd. ADR’s shares, which operate in the Healthcare, saw a trading volume of around 4.48 million for the day, a figure considerably lower than their average daily volume of 10.49 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly rise of 15.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 14.52B and boasts a workforce of 37226 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.16, with a change in price of +3.44. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 9,859,479 in trading volume during the last 100 days, posting a change of +36.02%.
TEVA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 2.70. Similarly, the long-term debt-to-equity ratio is also 2.46.
TEVA Stock Stochastic Average
Teva- Pharmaceutical Industries Ltd. ADR’s raw stochastic average for the past 50 days is presently 44.02%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 24.55%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 13.06% and 9.16%, respectively.
